Elior Group Stock Attempts a +2% Rebound After Hitting a Three-Year Low
Elior Group's stock attempts a technical recovery mid-session, following a sharp correction triggered by the lowering of its annual targets. The environment remains challenging, marked by a downgrade in analyst recommendation and a significant increase in short positions on the stock.
A Modest Rebound Leaves the Stock Far from Its Long-Term Moving Averages
Elior Group's stock is up 1.99% at €1.899 at midday, in a SBF 120 that is up 0.55%. The stock remains far from recovering the 28.07% decline recorded over the month, a direct consequence of the lowered annual guidance announced on May 20. The price is 23.12% below its MM20 (€2.47) and 28.34% below its MM200 (€2.65), a gap that illustrates the extent of the downturn. The RSI at 26 indicates a pronounced oversold condition, consistent with the test of the support at €1.86 touched during the new three-year low. During the first half of 2025-2026 (May 20, 2026), the group had revised its organic growth forecast to a range of 1% to 2% and targeted an adjusted EBITA margin around 3%, down from 3.5-3.7% previously.
Bernstein Aligns Its Target with the Price and Short Positions Intensify
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
This Tuesday, Bernstein lowered its price target from €3.00 to €1.90, while maintaining its underperform rating. The new target is almost identical to the current price, leaving little theoretical margin based on this recommendation. Based on the expected earnings per share, the stock is priced at about 5.3 times the earnings for the current fiscal year, according to the consensus of analysts surveyed. Meanwhile, the bearish bet has significantly intensified: eight funds now cumulatively hold 6.54% of the capital sold short, after an increase of 3.83 points in thirty days. This rapid rise reflects the arrival of institutional investors positioned against the stock since the earnings warning, a pressure signal that must be monitored without making it an isolated verdict. The next deadline for shareholders remains the tightening on the leverage ratio, expected to be about 3.5 times by the end of September 2026 according to the revised guidance.
SectorServices aux entreprises · Groupes hôteliers›Services de distribution et de restauration
Context
Period
Period: 2024-2025
Guidance from the release
Ces résultats confirment la trajectoire que nous avons engagée : redressement solide, croissance maîtrisée et ambition durable.
Retour à la profitabilité et à la distribution de dividendes, amélioration de la marge d'EBITA ajusté portée par la Restauration Collective (notamment US et péninsule ibérique) et optimisation opérationnelle ; poursuite du désendettement.
Risks mentioned
Non-renouvellement volontaire de contrats (impact en Italie mentionné)
Moindre demande de prestations d'intérim en France affectant les Multiservices
Ratio de levier encore élevé malgré désendettement (objectif ~3,0x)
Concentration sur grands contrats (dépendance à des signatures majeures)
Opportunities identified
Acquisition de 70% de Health Food & Beverage Group pour renforcer la position en Asie
Grand contrat avec West Virginia University comme relais de croissance en Amérique du Nord
Renforcement du mix clients et gains commerciaux sélectifs (stades UK, éducation, santé)
Amélioration continue de la rentabilité opérationnelle et plan d'innovation SI
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.